Hogan Lovells Publications | A Seat at the Table | 14 November 2019

FSMA update: FDA announces continuation of enforcement discretion for co-manufacturer supplier verification

On 6 November 2019 the U.S. Food and Drug Administration (FDA) announced in a Constituent Update that it will continue to exercise enforcement discretion with respect to certain supply-chain program requirements applicable to contract manufacturers (co-manufacturers).

The agency is taking this action to address situations where brand owners perform certain supply-chain program requirements on behalf of their co-manufacturers.

Read More: FSMA update: FDA announces continuation of enforcement discretion for co-manufacturer supplier verification